LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Search

ResMed Inc

Closed

SectorHealthcare

256.35 1.78

Overview

Share price change

24h

Current

Min

252.09

Max

258.17

Key metrics

By Trading Economics

Income

44M

393M

Sales

87M

1.4B

P/E

Sector Avg

25.77

108.767

Dividend yield

0.87

Profit margin

27.593

Employees

10,600

EBITDA

63M

566M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+19.05% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.87%

2.21%

Next Earnings

22 Apr 2026

Next Dividend date

19 Mar 2026

Next Ex Dividend date

7 May 2026

Market Stats

By TradingEconomics

Market Cap

777M

38B

Previous open

254.57

Previous close

256.35

News Sentiment

By Acuity

21%

79%

37 / 352 Healthcare

ResMed Inc Chart

Past performance is not a reliable indicator of future results.

Related News

26 Feb 2026, 22:04 UTC

Earnings

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26 Feb 2026, 23:55 UTC

Market Talk

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26 Feb 2026, 23:40 UTC

Acquisitions, Mergers, Takeovers

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26 Feb 2026, 23:37 UTC

Market Talk

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26 Feb 2026, 23:32 UTC

Earnings

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26 Feb 2026, 23:19 UTC

Acquisitions, Mergers, Takeovers

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 Feb 2026, 23:18 UTC

Acquisitions, Mergers, Takeovers

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 Feb 2026, 23:12 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

26 Feb 2026, 23:12 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26 Feb 2026, 23:01 UTC

Acquisitions, Mergers, Takeovers

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 Feb 2026, 23:00 UTC

Acquisitions, Mergers, Takeovers

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 Feb 2026, 23:00 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 Feb 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 Feb 2026, 22:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26 Feb 2026, 22:43 UTC

Market Talk

RBA Hike In March Is Being Underpriced -- Market Talk

26 Feb 2026, 22:33 UTC

Acquisitions, Mergers, Takeovers

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 Feb 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 Feb 2026, 22:13 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26 Feb 2026, 21:59 UTC

Earnings

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26 Feb 2026, 21:58 UTC

Acquisitions, Mergers, Takeovers

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 Feb 2026, 21:49 UTC

Earnings

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26 Feb 2026, 21:45 UTC

Earnings

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26 Feb 2026, 21:44 UTC

Earnings

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26 Feb 2026, 21:44 UTC

Earnings

Coles Expects Market to Remain Highly Competitive

26 Feb 2026, 21:44 UTC

Earnings

Coles Says Supermarket Customers Remain Value Oriented

26 Feb 2026, 21:43 UTC

Earnings

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26 Feb 2026, 21:43 UTC

Earnings

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26 Feb 2026, 21:42 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26 Feb 2026, 21:41 UTC

Earnings
Acquisitions, Mergers, Takeovers

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

19.05% upside

12 Months Forecast

Average 300.64 USD  19.05%

High 345 USD

Low 265 USD

Based on 13 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

8

Buy

5

Hold

0

Sell

Sentiment

By Acuity

37 / 352 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat